Screener
BioLife Solutions BLFS Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands, except per share and share data) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Available-for-sale securities, long-term | 30,654 | 31,250 |
| Intangible assets, net | 3,654 | 4,257 |
| Deferred tax assets, net | 42,233 | — |
| Goodwill | 208,587 | 208,587 |
| Total assets | $447,494 | $405,884 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,482 | $1,486 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's goodwill?
- BioLife Solutions (BLFS) reported goodwill of $208.59M in Q2 2026.
- How has BioLife Solutions's goodwill changed year-over-year?
- BioLife Solutions's goodwill decreased by 1.8% year-over-year, from $212.3M to $208.59M.
- What is the long-term trend for BioLife Solutions's goodwill?
- Over 5 years (2020 to 2025), BioLife Solutions's goodwill has grown at a 29.0% compound annual growth rate (CAGR), from $58.45M to $208.59M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about BioLife Solutions's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude